Please upgrade your browser.
The U.K.s health-cost regulator rejected Novartis AGs tumor treatment Afinitor for advanced kidney cancer in a draft ruling that is likely to curtail its use among publicly insured patients.
Patients treated with sunitinib in this study had improved HRQoL, compared with patients treated with IFNalpha. Treatment differences within the US cohort did not differ from those within the EU cohort.
A new study, 'Prognostic significance of Gremlin1 (GREM1) promoter CpG island hypermethylation in clear cell renal cell carcinoma,' is now available.
A deal struck with Swiss pharmaceutical giant Novartis AG will allow San Diego-based Prometheus to begin selling skin and kidney cancer drug Proleukin [IL-2] in the United States
Tumor necrosis is a potential marker of recurrence and survival after surgery for renal cell carcinoma. We determined whether a correlation exists between the amount (not just the presence/absence) of tumor necrosis, and metastasis-free, disease specific and overall survival after surgery for renal cell carcinoma.
Research will focus on identifying to what extent well water contaminated by arsenic is contributing to high rates of bladder and kidney cancer.
"It basically cooks the tumor to death," said Dr. Peter Julien, Chief of Thoracic Imaging at Cedars-Sinai Medical Center.
About 15 years ago, Robert's health began to fail. He had to retire after several heart attacks. And then it was kidney cancer, and then it was cancer of the esophagus
Pazopanib (Votrient) appears to delay disease progression by 54% in patients with advanced renal cell carcinoma, according to a study by Italian researchers.
|NeonCRM by Neon One|